Information

CARB-X is a biopharmaceutical business enterprise that specializes in biotechnology, antibiotics, vaccines, and fast diagnostics. The accelerator focuses on combating antibiotic-resistant bacteria by supporting the development of new antibiotics, vaccines, and rapid diagnostics. Entrepreneurs who join CARB-X benefit from access to significant funding, scientific expertise, business mentorship, and a global network of industry leaders and partners. The program is designed to accelerate the development of innovative solutions and bring them to market faster, addressing urgent public health needs.

How to Apply

To apply for CARB-X, interested parties should visit the official CARB-X website and navigate to the 'Apply' section. There, they can find detailed information about the application process, eligibility criteria, and submission deadlines. Applicants typically need to provide a comprehensive business plan, demonstrate their innovative approach to tackling antibiotic resistance, and show proof of concept or early-stage results.

Total number of startups invested: 104

Average Funding: The average funding round varies depending on the project needs and stage of development, but CARB-X typically provides significant financial support that can range from hundreds of thousands to several million dollars per project.

Industry: Biotechnology, Antibiotics, Vaccines, Fast Diagnostics

Market: Global